Gupta Dheeraj, Agarwal Ritesh, Aggarwal Ashutosh Nath, Maturu V N, Dhooria Sahajal, Prasad K T, Sehgal Inderpaul S, Yenge Lakshmikant B, Jindal Aditya, Singh Navneet, Ghoshal A G, Khilnani G C, Samaria J K, Gaur S N, Behera D
Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Lung India. 2013 Jul;30(3):228-67. doi: 10.4103/0970-2113.116248.
Chronic obstructive pulmonary disease (COPD) is a major public health problem in India. Although several International guidelines for diagnosis and management of COPD are available, yet there are lot of gaps in recognition and management of COPD in India due to vast differences in availability and affordability of healthcare facilities across the country. The Indian Chest Society (ICS) and the National College of Chest Physicians (NCCP) of India have joined hands to come out with these evidence-based guidelines to help the physicians at all levels of healthcare to diagnose and manage COPD in a scientific manner. Besides the International literature, the Indian studies were specifically analyzed to arrive at simple and practical recommendations. The evidence is presented under these five headings: (a) definitions, epidemiology, and disease burden; (b) disease assessment and diagnosis; (c) pharmacologic management of stable COPD; (d) management of acute exacerbations; and (e) nonpharmacologic and preventive measures. The modified grade system was used for classifying the quality of evidence as 1, 2, 3, or usual practice point (UPP). The strength of recommendation was graded as A or B depending upon the level of evidence.
慢性阻塞性肺疾病(COPD)是印度的一个主要公共卫生问题。尽管有若干关于COPD诊断和管理的国际指南,但由于印度全国各地医疗设施的可及性和可负担性存在巨大差异,该国在COPD的识别和管理方面仍存在许多差距。印度胸科学会(ICS)和印度国家胸科医师学院(NCCP)携手制定了这些循证指南,以帮助各级医疗保健机构的医生科学地诊断和管理COPD。除了国际文献外,还专门分析了印度的研究,以得出简单实用的建议。证据按照以下五个标题呈现:(a)定义、流行病学和疾病负担;(b)疾病评估和诊断;(c)稳定期COPD的药物治疗;(d)急性加重期的管理;以及(e)非药物和预防措施。采用改良的分级系统将证据质量分为1级、2级、3级或常规实践点(UPP)。根据证据水平,推荐强度分为A级或B级。